In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regulatory News In Brief

This article was originally published in The Gray Sheet

Executive Summary

FDA announces new, consumer-friendly MedWatch form. Agency issues final guidance on injector devices used with drugs or biologics. More regulatory news.

You may also be interested in...



First MERS-CoV In U.S. Diagnosed With FDA Emergency-Authorized Test Kit

The first documented Middle East respiratory syndrome coronavirus (MERS-CoV) case has appeared in the U.S., the Centers for Disease Control and Prevention confirmed May 2, and the individual was diagnosed with an MERS testing kit developed by CDC and approved for emergency use by FDA last June.

FDA Puts Strengthened Emergency Authority To Use For Diagnostics

The agency’s diagnostic office is putting to the test new authority to grant emergency use authorization for a product before an emergency is officially declared, with an upcoming coronavirus test and a recently authorized flu test.

Regulatory News In Brief

Sentinel workshop

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032123

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel